Jim Simons Timber Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.24 - $0.39 $205,302 - $333,617	-855,429 Reduced 98.19%	15,808 $5,000
Q1 2022 May 13, 2022	BUY	$0.28 - $0.41 $66,825 - $97,851	238,663 Added 37.73%	871,237 $335,000
Q4 2021 Feb 11, 2022	BUY	$0.38 - $0.89 $240,378 - $562,990	632,574 New	632,574 $240,000
Q3 2021 Nov 12, 2021	SELL	$0.89 - $1.18 $105,736 - $140,189	-118,805 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.06 - $2.25 $125,933 - $267,311	118,805 New	118,805 $145,000

Ticker TMBR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,524,992
Description
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.